ACR Appropriateness Criteria® Evaluation of Nipple Discharge: 2022 Update.


Journal

Journal of the American College of Radiology : JACR
ISSN: 1558-349X
Titre abrégé: J Am Coll Radiol
Pays: United States
ID NLM: 101190326

Informations de publication

Date de publication:
11 2022
Historique:
received: 29 08 2022
accepted: 07 09 2022
entrez: 27 11 2022
pubmed: 28 11 2022
medline: 30 11 2022
Statut: ppublish

Résumé

The type of nipple discharge dictates the appropriate imaging study. Physiologic nipple discharge is common and does not require diagnostic imaging. Pathologic nipple discharge in women, men, and transgender patients necessitates breast imaging. Evidence-based guidelines were used to evaluate breast imaging modalities for appropriateness based on patient age and gender. For an adult female or male 40 years of age or greater, mammography or digital breast tomosynthesis (DBT) is performed initially. Breast ultrasound is usually performed at the same time with rare exception. For males or females 30 to 39 years of age, mammography/DBT or breast ultrasound is performed based on institutional preference and individual patient considerations. For young women less than 30 years of age, ultrasound is performed first with mammography/DBT added if there are suspicious findings or if the patient is at elevated lifetime risk for developing breast cancer. There is a high incidence of breast cancer in males with pathologic discharge. Men 25 years and older should be evaluated using mammography/DBT and ultrasound added when indicted. In transfeminine (male-to-female) patients, mammography/DBT and ultrasound are useful due to the increased incidence of breast cancer. The ACR Appropriateness Criteria are evidence-based guidelines for specific clinical conditions that are reviewed annually by a multidisciplinary expert panel. The guideline development and revision process support the systematic analysis of the medical literature from peer-reviewed journals. Established methodology principles such as Grading of Recommendations Assessment, Development, and Evaluation or GRADE are adapted to evaluate the evidence. The RAND/UCLA Appropriateness Method User Manual provides the methodology to determine the appropriateness of imaging and treatment procedures for specific clinical scenarios. In those instances in which peer-reviewed literature is lacking or equivocal, experts may be the primary evidentiary source available to formulate a recommendation.

Identifiants

pubmed: 36436958
pii: S1546-1440(22)00654-8
doi: 10.1016/j.jacr.2022.09.020
pii:
doi:

Types de publication

Practice Guideline Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

S304-S318

Informations de copyright

Copyright © 2022 American College of Radiology. Published by Elsevier Inc. All rights reserved.

Auteurs

Matthew F Sanford (MF)

Lead Interpreting Physician, Sanford Health of Northern Minnesota, Bemidji, Minnesota. Electronic address: mfsanford@gmail.com.

Priscilla J Slanetz (PJ)

Panel Chair, Boston University School of Medicine, Boston, Massachusetts; Vice Chair, Academic Affairs, Department of Radiology, Associate Program Director, BMC Diagnostic Radiology Residency and Program Director, Academic Writing Program Boston Medical Center, Boston, Massachusetts.

Alana A Lewin (AA)

Panel Vice-Chair, New York University School of Medicine, New York, New York.

Arnold M Baskies (AM)

Virtua Willingboro Hospital, Willingboro, New Jersey; American College of Surgeons; Clinical Professor, Surgery, Rowan School of Medicine, Stratford, New Jersey.

Laura Bozzuto (L)

University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin; American College of Obstetricians and Gynecologists.

Susan A Branton (SA)

Medical Directo, Breast Health Center and Medical Staff President, UPMC North Central, Pittsburgh, Pennsylvania; American College of Surgeons.

Jessica H Hayward (JH)

University of California San Francisco, San Francisco, California.

Huong T Le-Petross (HT)

Breast MRI Director, The University of Texas MD Anderson Cancer Center, Houston, Texas.

Mary S Newell (MS)

Emory University Hospital, Atlanta, Georgia.

John R Scheel (JR)

Vice-Chair, Global Health, University of Washington, Seattle, Washington.

Richard E Sharpe (RE)

Mayo Clinic, Phoenix, Arizona; Member, ACR Peer Learning.

Gary A Ulaner (GA)

James & Pamela Muzzy Endowed Chair, Molecular Imaging and Therapy, Hoag Family Cancer Institute, Newport Beach, California.

Susan P Weinstein (SP)

Perelman School of Medicine of the University of Pennsylvania, Philadelphia, Pennsylvania; Associate Chair for Radiology Network Strategic Projects.

Linda Moy (L)

Specialty Chair, NYU Clinical Cancer Center, New York, New York.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH